Independence Blue Cross (Independence) hosted an American Cancer Society Cancer Action Network’s forum today at its headquarters to discuss and highlight research and emerging cancer treatments. The event focused on progress researchers are making in cancer treatment and prevention and the important role that federal funding has in fueling cancer research.
Nearly 50 key stakeholders from throughout the regional oncology community attended, including leaders in business, academia, public policy, patient advocacy, and physician groups. Dr. Ginny Calega, vice president of Medical Management and Policy at Independence Blue Cross, moderated a panel discussion with four leading cancer experts from Fox Chase Cancer Center, The University of Pennsylvania, Jefferson Pancreatic, Biliary, and Related Cancer Center, and the National Comprehensive Cancer Network.
Independence has long supported the American Cancer Society through community events and initiatives which include the annual Blue Cross Broad Street Run, Coaches vs. Cancer, and Hope Lodge. Independence also pledged to work with the National Colorectal Cancer Roundtable to reach an overall testing rate of 80 percent of people eligible for colon cancer screenings, both Independence members and employees, by 2018.